IT1042496B - Ciclizzazioni di peptidi - Google Patents

Ciclizzazioni di peptidi

Info

Publication number
IT1042496B
IT1042496B IT27171/75A IT2717175A IT1042496B IT 1042496 B IT1042496 B IT 1042496B IT 27171/75 A IT27171/75 A IT 27171/75A IT 2717175 A IT2717175 A IT 2717175A IT 1042496 B IT1042496 B IT 1042496B
Authority
IT
Italy
Prior art keywords
cycling
peptides
Prior art date
Application number
IT27171/75A
Other languages
English (en)
Italian (it)
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Application granted granted Critical
Publication of IT1042496B publication Critical patent/IT1042496B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/067General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for sulfur-containing functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/585Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/15Oxytocin or vasopressin; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/16Somatostatin; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT27171/75A 1974-09-12 1975-09-11 Ciclizzazioni di peptidi IT1042496B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US505344A US3929758A (en) 1974-09-12 1974-09-12 Cyclization of cysteine-containing peptides

Publications (1)

Publication Number Publication Date
IT1042496B true IT1042496B (it) 1980-01-30

Family

ID=24009941

Family Applications (1)

Application Number Title Priority Date Filing Date
IT27171/75A IT1042496B (it) 1974-09-12 1975-09-11 Ciclizzazioni di peptidi

Country Status (16)

Country Link
US (1) US3929758A (US06262066-20010717-C00424.png)
JP (1) JPS5833864B2 (US06262066-20010717-C00424.png)
AU (1) AU498757B2 (US06262066-20010717-C00424.png)
BE (1) BE833336A (US06262066-20010717-C00424.png)
CA (1) CA1045117A (US06262066-20010717-C00424.png)
DE (1) DE2540780A1 (US06262066-20010717-C00424.png)
DK (1) DK409775A (US06262066-20010717-C00424.png)
ES (1) ES440922A1 (US06262066-20010717-C00424.png)
FR (1) FR2284591A1 (US06262066-20010717-C00424.png)
GB (1) GB1527252A (US06262066-20010717-C00424.png)
HU (1) HU175202B (US06262066-20010717-C00424.png)
IT (1) IT1042496B (US06262066-20010717-C00424.png)
LU (1) LU73386A1 (US06262066-20010717-C00424.png)
NL (1) NL179909C (US06262066-20010717-C00424.png)
SU (1) SU849998A3 (US06262066-20010717-C00424.png)
YU (1) YU39747B (US06262066-20010717-C00424.png)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4066634A (en) * 1976-08-31 1978-01-03 American Home Products Corporation Purification of synthetic somatostatin
US4304692A (en) * 1978-07-24 1981-12-08 Armour Pharmaceutical Company Synthesis of biologically active peptides
US4212795A (en) * 1978-11-13 1980-07-15 Armour Pharmaceutical Company Cyclization of peptides
US4397780A (en) * 1982-02-12 1983-08-09 Armour Pharmaceutical Company Leucine22 -calcitonin
US4391747A (en) * 1982-02-12 1983-07-05 Armour Pharmaceutical Company Des asparagine-3-calcitonin
US4401593A (en) * 1982-02-12 1983-08-30 Armour Pharmaceutical Company Glycine - 8 calcitonin
US4388235A (en) * 1982-02-12 1983-06-14 Armour Pharmaceutical Company Synthesis of peptides
US4469632A (en) * 1982-09-24 1984-09-04 Armour Pharmaceutical Company D-Arginine24 calcitonin
US4444681A (en) * 1982-09-24 1984-04-24 Armour Pharmaceutical Company L-Tyrosine21 calcitonin
US4451395A (en) * 1982-11-08 1984-05-29 Armour Pharmaceutical Company Des-serine2 -des-tyrosine22 calcitonin
JPS60500054A (ja) * 1983-02-15 1985-01-17 ア−マ−・フア−マシユ−テイカル・カンパニ− デス−アスパラギン−3−カルシトニン
JPS60500055A (ja) * 1983-02-15 1985-01-17 ア−マ−・ファ−マシュ−ティカル・カンパニ− グリシン−8−カルシトニン
US4549986A (en) * 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP
US4623716A (en) * 1984-11-01 1986-11-18 Usv Pharmaceutical Corp. Process for the preparation and purification of peptides
JPH0517511Y2 (US06262066-20010717-C00424.png) * 1985-09-30 1993-05-11
US4644054A (en) * 1985-10-01 1987-02-17 Kempe Tomas G Calcitonin analogs with amino acid substituents at position 31
US4658014A (en) * 1985-12-20 1987-04-14 Kempe Tomas G Synthetic peptides with calcitonin-like activity
US4697002A (en) * 1985-12-23 1987-09-29 Kempe Tomas G Calcitonin gene related peptide analogs with amino acid subdstituents at the penultimate position 36
US4687839A (en) * 1985-12-23 1987-08-18 Kempe Tomas G Calcitonin gene related peptide analogs with C-terminal D-amino acid substituents
US4820804A (en) * 1987-04-21 1989-04-11 Rorer Pharmaceutical Corporation Analogs of [1,7-di-alanine, des-19-leucine]calcitonin
US4824936A (en) * 1987-05-06 1989-04-25 Rorer Pharmaceutical Corporation (19-Alanine) calcitonin
JP2682061B2 (ja) * 1988-10-07 1997-11-26 藤沢薬品工業株式会社 ペプチドの分子内ジスルフィド結合の形成法
ES2051647B1 (es) * 1992-12-10 1995-01-16 Lipotec Sa Procedimiento para la preparacion de calcitonina de salmon.
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
KR100193104B1 (ko) * 1993-06-29 1999-06-15 훼링비.브이 비강 투여를 위한 데스모프레신 조성물
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
ATE193892T1 (de) * 1993-06-29 2000-06-15 Ferring Bv Synthese zyklischer peptide
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
US7723474B2 (en) * 2003-10-21 2010-05-25 The Regents Of The University Of California Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
WO2008077621A1 (de) * 2006-12-23 2008-07-03 Aplagen Gmbh Verfahren zur ausbildung von disulfidbrücken
JP2014517832A (ja) 2011-05-10 2014-07-24 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 自己免疫疾患を治療するための方法及び医薬組成物
GB201313352D0 (en) 2013-07-26 2013-09-11 Isis Innovation Identification of peptide ligands
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
WO2016184784A1 (en) 2015-05-15 2016-11-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Peptides including binding domain of plasmodium falciparum proteins (cbp1 and cbp2) to chemokine cx3cl1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560521A (en) * 1967-08-07 1971-02-02 Merck & Co Inc Blocking groups for cysteine containing peptides
US3679655A (en) * 1968-06-28 1972-07-25 Hoechst Ag N,n-disubstituted aminoethylcarbamyl protecting groups for cysteine
US3849388A (en) * 1968-10-15 1974-11-19 Ciba Geigy Corp Analogues of human thyrocalcitonin
DE1950711A1 (de) * 1968-10-15 1970-04-30 Ciba Geigy Neue Peptide und Verfahren zu ihrer Herstellung
GB1294771A (en) * 1969-01-31 1972-11-01 Sandoz Ltd Thyrocalcitonin derivative
CH523868A (de) * 1969-10-22 1972-06-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Dotriacontapeptidamide und ihrer Derivate
US3801561A (en) * 1970-10-29 1974-04-02 Sandoz Ltd Derivatives of salmon thyrocalcitonin
ZA723287B (en) * 1971-06-18 1973-02-28 Hoffmann La Roche Nonapeptides and processes for the preparation thereof
BE785933A (fr) * 1971-07-07 1973-01-08 Ciba Geigy Procede de preparation de peptides contenant de la cystine

Also Published As

Publication number Publication date
CA1045117A (en) 1978-12-26
AU8473775A (en) 1977-03-17
FR2284591A1 (fr) 1976-04-09
YU230075A (en) 1982-02-28
SU849998A3 (ru) 1981-07-23
LU73386A1 (US06262066-20010717-C00424.png) 1976-04-13
DE2540780C2 (US06262066-20010717-C00424.png) 1989-05-24
NL179909C (nl) 1986-12-01
HU175202B (hu) 1980-06-28
AU498757B2 (en) 1979-03-22
FR2284591B1 (US06262066-20010717-C00424.png) 1978-12-01
YU39747B (en) 1985-04-30
JPS5156448A (US06262066-20010717-C00424.png) 1976-05-18
GB1527252A (en) 1978-10-04
DE2540780A1 (de) 1976-04-01
ES440922A1 (es) 1977-06-16
JPS5833864B2 (ja) 1983-07-22
BE833336A (fr) 1975-12-31
DK409775A (da) 1976-03-13
US3929758A (en) 1975-12-30
NL7510761A (nl) 1976-03-16

Similar Documents

Publication Publication Date Title
IT1042496B (it) Ciclizzazioni di peptidi
SE430067B (sv) Fluoracetylerat etylcellulosaderivat
AR208904A1 (es) Mezclas de copolieteresteres
IT1050317B (it) Procedimento di decaffeinizzazione
FR2279417A1 (fr) Composition de peptide
JPS514579A (ja) Shinkushadanki
SE406246B (sv) Av moduler uppbyggd omkopplare
IT1028363B (it) Miscele di polieteri
SE7509532L (sv) Amid
JPS5128387A (ja) Kokyuyofukurotai
JPS5173265A (ja) Shinkushadanki
JPS5157789A (ja) Koritsutaikisokuseihori aa orefuinno seizohoho
JPS512336A (ja) Terebishingofugokahoshiki
JPS5149490A (ja) Heisetsusaretafukusujono of keeburuno kyuyuhoho
JPS5152604A (ja) Purehabuyoheki
TR18286A (tr) Galvanik almanya cumhuriyeti
JPS5120570A (ja) Shinkushadanki
JPS5128671A (ja) Shinkushadanki
JPS5163470A (ja) Shinkuparupu
JPS5110369A (ja) Shinkushadanki
BE825789A (fr) Anti-transpirant
JPS5173272A (ja) Gasuzetsuenkaiheisochinichotsuketsusuru of keeburunokyuyuhoshiki
JPS5153392A (ja) Mankonbeanofumidan
JPS5173271A (ja) Gasuzetsuenkaiheisochinichotsuketsusuru of keeburunokyuyuhoshiki
JPS516319A (ja) Purehaburuumu